Correlation of Pre- and Post-operative Cancer Imaging Techniques
NCT04776291 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2025-04-16
Summary
Various imaging modalities are used in medical diagnosis such as MRI, CT and PET. The images are sometimes acquired at different times and in different body positions, and thus need to be aligned for precise diagnosis and treatment planning. Different image modalities provide complementary information about the anatomical structure under study. Image registration techniques enable multimodality images to be projected onto a common coordinate system, so that these images can be aligned and spatial correspondences can be established between the images.
This research project aims to investigate the information provided by functional PET and CT images about the tumour environment in lung cancer patients by registering functional PET and CT images with the pathology images acquired from the same patient. On identification of specific region of interest on the functional imaging the investigators will then be able to interrogate the tumour biology. In many cancers, the tumour environment is usually composed of a heterogeneous mass of tissue. The discrimination and classification of the carcinoma substructures is of paramount importance in the radiotherapy planning stage, as a given treatment may be more or less suitable depending on the local characteristics of the tumour. For instance, in hypoxic regions (areas inside the tumour with very low oxygen supply), radiotherapy performs poorly and strategies to intensify treatment to those areas could be investigated.
This project will develop a framework for automatic registration of pathology images, which are taken from a surgically extracted lung tumour, with the corresponding PET/CT scan acquired from the patient before surgery. The registration of these images is essential for the evaluation of the performance of different PET radiotracers.
Conditions
Interventions
- RADIATION
-
4D PET-CT Scan
The recruited patients will have a 4d PET-CT scan that is additional to the usual care.
Sponsors & Collaborators
-
NHS Greater Glasgow and Clyde
collaborator OTHER -
University of Strathclyde
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-15
- Primary Completion
- 2024-05-01
- Completion
- 2024-06-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
NCT00227539 ·Status: COMPLETED ·Phase: PHASE2
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
NCT03568799 ·Status: UNKNOWN ·Phase: NA
-
[18F]HX4 PET/CT Imaging for Detection of Hypoxia
NCT02976883 ·Status: COMPLETED ·Phase: PHASE2
-
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
NCT01254591 ·Status: UNKNOWN ·Phase: NA
-
PET Response During Chemoradiation of Lung Cancer
NCT02315053 ·Status: COMPLETED ·Phase: NA
-
PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
NCT04272658 ·Status: RECRUITING
-
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949 ·Status: RECRUITING ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging
NCT04017104 ·Status: UNKNOWN
-
Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
NCT07301814 ·Status: RECRUITING
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
Imaging Study Compare 4DCT Image
NCT01626001 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging NSCLC Treatment Response to Immunotherapy
NCT02753569 ·Status: COMPLETED
-
Study of Different Gating Techniques for PET Image of Lung and Liver Lesions
NCT05779865 ·Status: COMPLETED
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709 ·Status: TERMINATED ·Phase: NA
-
Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients
NCT05933239 ·Status: RECRUITING ·Phase: PHASE2
-
4D-MRI for Precision Medicine
NCT04657042 ·Status: RECRUITING
-
PET/MR Imaging in Lung Cancer
NCT03739281 ·Status: TERMINATED ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
[68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer
NCT06165874 ·Status: RECRUITING ·Phase: NA
-
Radiolabelled Nectin-4 Targeted LMW Probe PET/CT in Patients With Lung Lesions
NCT06648317 ·Status: RECRUITING
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2